New Pitt Research Team Finds Different Immune Response in Severe Asthma; To Continue Such Studies
Click here to read the story.
FDA Advisory Committee Recommends New Asthma Drug for Approval
The Pulmonary-Allergy Drugs Advisory Committee of the US Food and Drug Administration recently voted unanimously to recommend mepolizumab as a maintenance treatment for eosinophillic asthma. When severe, this form of asthma can be especially difficult to control, as it may resist treatment even when using high dose steroids. Patients suffering with this type of asthma currently have few viable treatment options and the options available to them are usually associated with devastating side effects such as, sleep and emotional problems, hypertension, thinning bones (osteoporosis) and weight gain. This drug works by blocking a chemical called interleukin-5. This chemical is vital to the survival of the eosinophils which contribute to the symptoms seen in patients with eosinophilic asthma. This treatment has been recommended for adults but there is currently not enough research to support efficacy and safety in children. It will be relatively easy to identify patients that could benefit from this treatment by using a simple blood test to measure the amount of eosinophils present in the blood. This blood test is available everywhere. This treatment should provide hope for the community of those that suffer from severe forms of asthma and the people who care for them. To date the drug appears to be safe and well tolerated and it’s given through an injection done once a month. We are hopeful that mepolizumab will soon finish the approval process and be available to patients within the next few months where it will have opportunity to impact many patients’ lives.
Congrats to Dr. Wenzel
Many Patients Being Misdiagnosed With Asthma
Dr. Wenzel contributed to a segment that aired on KDKA about the misdiagnosing of Asthma. Click here to read the article and make sure to watch the video.
Asthma Institute Reports on New Asthmatic Disease
Researchers at the Asthma Institute report about patients with a new and novel type of severe asthma . These severe asthma patients, all of whom were using prednisone and other steroids chronically, have generally responded well to alternative, non-traditional asthma therapies. Click here to find out more.
Costs Of Treating Asthma Soaring.
Elisabeth Rosenthal at the New York Times examines how rising costs are affecting familes with and without proper insurance coverage. Click here to read the article.
Can Vitamin D Help Asthma Sufferers?
Dr. Wenzel talks about a study evaluating the effects of Vitamin D for the treatment of asthma.
click here to see Dr. Wenzels interview.
- Pregnancy and Asthma
- Asthma and Exercise
- Around the World for Asthma Answers – International Patients
- Asthma Institute Community Events
- Asthma Support Group
- Allergist and Clinical Immunologist, Vocal Cord Dysfunction, and Mental Notes on Asthma
- What is Spirometry?
- Managing Asthma During the Winter Season
- Body Weight and Asthma, Clinical Research Studies – What are they and why do they help?
- Asthma Institute Supports racewalker and severe asthmatic in Boston Marathon
- Asthma Updates – Raising Expectations for Life with Asthma
- New Name!, H1N1 Vaccine Study, and Major Grants: AsthmaNet and Go
- New England Journal of Medicine Publishes Pitt/UPMC Study Finding Potential Asthma Treatment
- Late-Onset Asthma in Obese Individuals Could Be Due to an Amino Acid Imbalance, Says Pitt-Led Study
- Pitt Team Finds New Type of Severe Asthma, Can Be Treated with Drugs that Suppress the Immune System
- Pitt Team Shows How Childhood Viral Infection Leads to Increased Risk For Allergic Asthma as Adult
- When good cells go bad, allergic asthma can develop
- Study here to determine if Vitamin D eases asthma
- Asthma patients recruited for vitamin D study
- Allergy season arrives early following mild winter
- World Asthma Day 2011 - To view the Asthma Day 2011 flyer, click here.
- Vitamin D Research Press Release
- Initial AI Press Release
- ATS 2010 Scientific Excellence Award